262 related articles for article (PubMed ID: 27614920)
1. Synthesis and preclinical characterization of 1-(6'-deoxy-6'-[
Wanek T; Kreis K; Križková P; Schweifer A; Denk C; Stanek J; Mairinger S; Filip T; Sauberer M; Edelhofer P; Traxl A; Muchitsch VE; Mereiter K; Hammerschmidt F; Cass CE; Damaraju VL; Langer O; Kuntner C
Bioorg Med Chem; 2016 Nov; 24(21):5326-5339. PubMed ID: 27614920
[TBL] [Abstract][Full Text] [Related]
2. β -[
Kumar P; Roselt P; Reischl G; Cullinane C; Beiki D; Ehrlichmann W; Binns D; Naimi E; Yang J; Hicks R; Machulla HJ; Wiebe LI
Curr Radiopharm; 2017; 10(2):93-101. PubMed ID: 28294075
[TBL] [Abstract][Full Text] [Related]
3. [
Schweifer A; Maier F; Ehrlichmann W; Lamparter D; Kneilling M; Pichler BJ; Hammerschmidt F; Reischl G
Nucl Med Biol; 2016 Dec; 43(12):759-769. PubMed ID: 27693670
[TBL] [Abstract][Full Text] [Related]
4. PET imaging of tumor hypoxia using 18F-labeled pimonidazole.
Busk M; Jakobsen S; Horsman MR; Mortensen LS; Iversen AB; Overgaard J; Nordsmark M; Ji X; Lee DY; Raleigh JR
Acta Oncol; 2013 Oct; 52(7):1300-7. PubMed ID: 23962243
[TBL] [Abstract][Full Text] [Related]
5. In Vivo Ester Hydrolysis as a New Approach in Development of Positron Emission Tomography Tracers for Imaging Hypoxia.
Zhang L; Yao X; Cao J; Hong H; Zhang A; Zhao R; Zhang Y; Zha Z; Liu Y; Qiao J; Zhu L; Kung HF
Mol Pharm; 2019 Mar; 16(3):1156-1166. PubMed ID: 30676751
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of hypoxia imaging agent 1-(5-deoxy-5-fluoro-α-D-arabinofuranosyl)-2-nitroimidazole using microfluidic technology.
Bouvet VR; Wuest M; Wiebe LI; Wuest F
Nucl Med Biol; 2011 Feb; 38(2):235-45. PubMed ID: 21315279
[TBL] [Abstract][Full Text] [Related]
7. Syntheses of 2-nitroimidazole derivatives conjugated with 1,4,7-triazacyclononane-N,N'-diacetic acid labeled with F-18 using an aluminum complex method for hypoxia imaging.
Hoigebazar L; Jeong JM; Lee JY; Shetty D; Yang BY; Lee YS; Lee DS; Chung JK; Lee MC
J Med Chem; 2012 Apr; 55(7):3155-62. PubMed ID: 22443100
[TBL] [Abstract][Full Text] [Related]
8. 2-Nitroimidazole-Furanoside Derivatives for Hypoxia Imaging-Investigation of Nucleoside Transporter Interaction,
Maier FC; Schweifer A; Damaraju VL; Cass CE; Bowden GD; Ehrlichmann W; Kneilling M; Pichler BJ; Hammerschmidt F; Reischl G
Pharmaceuticals (Basel); 2019 Feb; 12(1):. PubMed ID: 30781409
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of two novel 2-nitroimidazole derivatives as potential PET radioligands for tumor imaging.
Zha Z; Zhu L; Liu Y; Du F; Gan H; Qiao J; Kung HF
Nucl Med Biol; 2011 May; 38(4):501-8. PubMed ID: 21531287
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Bioevaluation of Novel [
Yang X; Wang F; Zhu H; Yang Z; Chu T
Mol Pharm; 2019 May; 16(5):2118-2128. PubMed ID: 30964298
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of ¹⁸F-labeled fluoropropyl tryptophan analogs as potential PET probes for tumor imaging.
Chiotellis A; Mu L; Müller A; Selivanova SV; Keller C; Schibli R; Krämer SD; Ametamey SM
Eur J Med Chem; 2013; 70():768-80. PubMed ID: 24239624
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of an
Nunes PSG; Zhang Z; Kuo HT; Zhang C; Rousseau J; Rousseau E; Lau J; Kwon D; Carvalho I; Bénard F; Lin KS
J Labelled Comp Radiopharm; 2018 Apr; 61(4):370-379. PubMed ID: 29247455
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and in vitro and in vivo evaluation of an (18)F-labeled neuropeptide Y analogue for imaging of breast cancer by PET.
Hofmann S; Maschauer S; Kuwert T; Beck-Sickinger AG; Prante O
Mol Pharm; 2015 Apr; 12(4):1121-30. PubMed ID: 25748228
[TBL] [Abstract][Full Text] [Related]
14. PET of hypoxia with 89Zr-labeled cG250-F(ab')2 in head and neck tumors.
Hoeben BA; Kaanders JH; Franssen GM; Troost EG; Rijken PF; Oosterwijk E; van Dongen GA; Oyen WJ; Boerman OC; Bussink J
J Nucl Med; 2010 Jul; 51(7):1076-83. PubMed ID: 20554724
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo evaluation of [(18)F]F-GAZ, a novel oxygen-mimetic azomycin-glucose conjugate, for imaging hypoxic tumor.
Wuest M; Kumar P; Wang M; Yang J; Jans HS; Wiebe LI
Cancer Biother Radiopharm; 2012 Oct; 27(8):473-80. PubMed ID: 22746267
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo evaluation of the effects of aluminum [¹⁸F]fluoride radiolabeling on an integrin αvβ₆-specific peptide.
Hausner SH; Bauer N; Sutcliffe JL
Nucl Med Biol; 2014 Jan; 41(1):43-50. PubMed ID: 24267053
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of [
Nakata N; Kiriu M; Okumura Y; Zhao S; Nishijima KI; Shiga T; Tamaki N; Kuge Y; Matsumoto H
Nucl Med Biol; 2019 Mar; 70():39-45. PubMed ID: 30836255
[TBL] [Abstract][Full Text] [Related]
18. Radiopharmacological evaluation of 6-deoxy-6-[18F]fluoro-D-fructose as a radiotracer for PET imaging of GLUT5 in breast cancer.
Wuest M; Trayner BJ; Grant TN; Jans HS; Mercer JR; Murray D; West FG; McEwan AJ; Wuest F; Cheeseman CI
Nucl Med Biol; 2011 May; 38(4):461-75. PubMed ID: 21531283
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and radiopharmacological characterization of 2beta-carbo-2'-[18F]fluoroethoxy-3beta-(4-bromo-phenyl)tropane ([18F]MCL-322) as a PET radiotracer for imaging the dopamine transporter (DAT).
Wuest F; Berndt M; Strobel K; van den Hoff J; Peng X; Neumeyer JL; Bergmann R
Bioorg Med Chem; 2007 Jul; 15(13):4511-9. PubMed ID: 17467995
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of [
Sun W; Falzon C; Naimi E; Akbari A; Wiebe LI; Tandon M; Kumar P
Curr Radiopharm; 2019; 12(1):49-57. PubMed ID: 30338747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]